The Similarities and Differences Between Glomerular vs. Non-glomerular Diagnoses on Intelligence and Executive

Stephen R Hooper1, Rebecca J Johnson2, Marc Lande3

  • 1Department of Allied Health Sciences, School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States.

Frontiers in Neurology
|January 6, 2022
PubMed

Insights

Pediatric chronic kidney disease (CKD) heterogeneity impacts neurocognition minimally. Glomerular vs. non-glomerular diagnoses showed few differences, except for inhibitory control in hypertensive patients.

Area of Science:

  • Pediatric Nephrology
  • Neuropsychology
  • Chronic Kidney Disease Research

Background:

  • Pediatric chronic kidney disease (CKD) is heterogeneous, but its impact on neurocognitive functioning is not well understood.
  • Previous research has not explored neurocognitive differences based on glomerular (G) versus non-glomerular (NG) CKD diagnoses.

Purpose of the Study:

  • To investigate neurocognitive functioning in children and adolescents with CKD, comparing those with glomerular (G) versus non-glomerular (NG) diagnoses.
  • To determine if CKD diagnostic category influences specific neurocognitive domains.

Main Methods:

  • Utilized data from the North American CKiD Study, including 1,003 children and adolescents with mild to moderate CKD.
  • Compared neurocognitive measures (IQ, inhibitory control, attention, problem solving, working memory, executive functioning) between the G Group (n=260) and NG Group (n=743).
  • Employed linear mixed model analyses, adjusting for relevant covariates.

Main Results:

  • No significant differences were found between G and NG groups in IQ, problem solving, working memory, or attention regulation.
  • A trend suggested better overall executive function ratings for the G group (p < 0.07).
  • A significant interaction between G diagnosis and hypertension was observed for inhibitory control (p < 0.003), with hypertensive G-CKD patients performing worse.

Conclusions:

  • The distinction between glomerular and non-glomerular pediatric CKD has minimal impact on most neurocognitive functions.
  • Specific differences in inhibitory control were noted in patients with glomerular CKD and hypertension.
  • Further research is warranted to explore pediatric CKD heterogeneity's effects on neurocognition across different disease stages or models.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
11
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
97
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
105
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
186
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
6
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
139